(Q57616453)

4

object named as

Michael Criqui

0 references

Robyn L McClelland

2

object named as

Robyn L McClelland

0 references

Joseph F Polak

6

object named as

Joseph F Polak

0 references

author name string

Parveen K Garg

1

0 references

Nancy S Jenny

3

0 references

Kiang Liu

5

0 references

Neal W Jorgensen

Lipoprotein-associated phospholipase A2: a novel marker of cardiovascular risk and potential therapeutic target

7

0 references

publication date

27 June 2011

0 references

published in

Vascular Medicine

0 references

volume

16

0 references

issue

4

0 references

page(s)

247-252

0 references

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1358863X11411360

Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X11411360

Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X11411360

Lysophosphatidylcholine regulates human microvascular endothelial cell expression of chemokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X11411360

Lysophosphatidylcholine-induced modulation of Ca(2+)-activated K(+)channels contributes to ROS-dependent proliferation of cultured human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X11411360

Lysophosphatidylcholine inhibits endothelial cell migration by increasing intracellular calcium and activating calpain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X11411360

Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X11411360

Lipoprotein-associated phospholipase A2 is an independent marker for coronary endothelial dysfunction in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X11411360

Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X11411360

Endothelial function predicts progression of carotid intima-media thickness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X11411360

Interrelations between brachial endothelial function and carotid intima-media thickness in young adults: the cardiovascular risk in young Finns study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X11411360

Multi-Ethnic Study of Atherosclerosis: objectives and design

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X11411360

Lipoprotein-associated phospholipase A2 and measures of extracoronary atherosclerosis: the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X11411360

Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X11411360

Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X11411360

Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X11411360

Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X11411360

Platelet-activating factor acetylhydrolase activity indicates angiographic coronary artery disease independently of systemic inflammation and other risk factors: the Ludwigshafen Risk and Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X11411360

Association of lipoprotein-associated phospholipase A2 levels with coronary artery disease risk factors, angiographic coronary artery disease, and major adverse events at follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X11411360

Cardiovascular events with increased lipoprotein-associated phospholipase A(2) and low high-density lipoprotein-cholesterol: the Veterans Affairs HDL Intervention Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X11411360